Prescription-event and other forms of epidemiological monitoring of side-effects in the UK

被引：20

作者：

Dunn, N

Mann, RD ^{[1
]}

机构：

[1] Univ Southampton, Drug Safety Res Unit, Southampton SO31 1AA, Hants, England

[2] Univ Southampton, Fac Med Hlth & Biol Sci, Southampton SO31 1AA, Hants, England

来源：

CLINICAL AND EXPERIMENTAL ALLERGY | 1999年 / 29卷

关键词：

adverse drug reactions; pharmacoepidemiology; spontaneous reporting; yellow card scheme; prescription event monitoring;

D O I：

10.1046/j.1365-2222.1999.0290s3217.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

The post-marketing surveillance (PMS) of drugs is necessary because of the limited size of the clinical safety database at the time of marketing. The principal hypothesis-generating methods of PMS are spontaneous reporting (e.g. the yellow card) and Prescription Event Monitoring. These methods are discussed in this chapter and certain basic pharmacoepidemiological issues that are relevant are briefly reviewed.

引用

页码：217 / 239

页数：23

共 71 条

[1] PRIMARY NONCOMPLIANCE WITH PRESCRIBED MEDICATION IN PRIMARY-CARE
BEARDON, PHG
MCGILCHRIST, MM
MCKENDRICK, AD
MCDEVITT, DG
MACDONALD, TM
[J]. BRITISH MEDICAL JOURNAL, 1993, 307 (6908) : 846 - 848
[2] BEARDON PHG, 1989, Q J MED, V71, P497
[3] BEM J L, 1988, Pharmaceutical Medicine (London), V3, P35
[4] *BMA, 1996, REP ADV DRUG REACT
[5] POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - MORTALITY DURING 2ND, 3RD, AND 4TH YEARS OF FOLLOW UP
COLINJONES, DG
LANGMAN, MJS
LAWSON, DH
VESSEY, MP
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1985, 291 (6502): : 1084 - 1088
[6] DERBY LE, 1993, PHARMACOTHERAPY, V13, P353
[7] DUNN N, 1997, PHARMACOEPIDEMIOL S2, V6
[8] Galactorrhoea with moclobemide
Dunn, NR
Freemantle, SN
Pearce, GL
Mann, RD
[J]. LANCET, 1998, 351 (9105) : 802 - 802
[9] Dunn NR, 1997, PHARMACOEPIDEM DR S, V6, P283, DOI 10.1002/(SICI)1099-1557(199707)6:4<283::AID-PDS270>3.0.CO
[10] 2-F

← 1 2 3 4 5 6 7 8 →